NYSE:IMS IMS Health (IMS) Stock Price, News & Analysis → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free IMS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$31.34▼$31.3450-Day Range N/A52-Week Range$22.36▼$31.59VolumeN/AAverage Volume1.27 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IMS Health alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About IMS Health Stock (NYSE:IMS)IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company's data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company's principal information offerings include national information offerings, sub-national information offerings and OneKey. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications and other services.Read More Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here IMS Stock News HeadlinesMarch 20, 2024 | msn.comGeorge Thorogood & The Destroyers, Gin Blossoms headline Miller Lite Carb Day at IMSMarch 20, 2024 | finance.yahoo.comathenahealth Delivers Value-Based Care Success, Enables Significant Growth for Integrated Medical ServicesMarch 28, 2024 | Behind the Markets (Ad)4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 18, 2024 | msn.comED Attaches Rs 1 Crore Property In Money Laundering Probe Linked To SC/ST Scholarship ScamMarch 17, 2024 | msn.comUttarakhand SC, ST scholarship scam: ED attaches assets worth over Rs 1 cr in HaridwarMarch 15, 2024 | msn.comResearchers find link between gut bacteria and the success of milk-allergy oral immunotherapyMarch 15, 2024 | msn.comExploring the Link Between Gut Health and Effective Milk Allergy TreatmentMarch 14, 2024 | finance.yahoo.comAugury and DSV Announce Groundbreaking Partnership to Introduce New Parts As a Service (PaaS) Solution for Industrial ManufacturingMarch 28, 2024 | Behind the Markets (Ad)4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 14, 2024 | benzinga.comIQVIA Hldgs's Options Frenzy: What You Need to KnowMarch 5, 2024 | msn.comRev 2024 announces celebrity chef for IU Health fundraiserMarch 3, 2024 | msn.comGombe govt confirms meningitis outbreakFebruary 29, 2024 | msn.comMISD webinar focuses on health, PE and summer school programsFebruary 28, 2024 | msn.comMental Health Treatments Demand Jumps, Hims & Hers SlouchesFebruary 27, 2024 | msn.comHIMS Stock Breaks Out On Powerful Turnaround QuarterFebruary 26, 2024 | msn.comIMS in trademark row with F1 over "greatest spectacle in racing" sloganFebruary 25, 2024 | msn.comEgg freezing helps preserve woman’s fertility: DocFebruary 24, 2024 | msn.comArk City first responders honored for saving teenFebruary 22, 2024 | finanznachrichten.deNava Health Opens in Boca Raton, FloridaFebruary 21, 2024 | msn.comDoctors from across India to attend 3-day 29th national meet of IMS from Feb 25 in PrayagrajFebruary 16, 2024 | msn.comFor Everence Federal Credit Union, bringing banking services to Kensington is an act of faithFebruary 16, 2024 | msn.comWhat Are The Complications Fatty Liver? A Review By DoctorsFebruary 15, 2024 | msn.comNew IMS and SUM Hospital campus developed in Odisha, IndiaFebruary 13, 2024 | msn.comNew nanosensors make diagnostic procedures more sensitiveFebruary 6, 2024 | msn.com‘Kashi needs cardiology institute to ease patient load’February 2, 2024 | sports.yahoo.comHe was an IndyCar driver. She was a nurse. Love story of Ed Carpenter & his wife, HeatherJanuary 30, 2024 | msn.comMolecular simulation AI tool reveals unresolved structure of transporter proteinSee More Headlines Receive IMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMS Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/27/2016Today3/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:IMS CUSIPN/A CIK1595262 Webwww.imshealth.com Phone+1-203-4484600FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report IMS Stock Analysis - Frequently Asked Questions How were IMS Health's earnings last quarter? IMS Health Holdings Inc (NYSE:IMS) released its quarterly earnings results on Wednesday, July, 27th. The information technology services provider reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.38 by $0.03. The information technology services provider had revenue of $802 million for the quarter, compared to analyst estimates of $796.93 million. The company's revenue was up 112.4% compared to the same quarter last year. During the same period last year, the company earned $0.37 EPS. What other stocks do shareholders of IMS Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other IMS Health investors own include Frontier Communications (FTR), Cognizant Technology Solutions (CTSH), Dollar Tree (DLTR), Oxford Immunotec Global (OXFD), Exact Sciences (EXAS), Ford Motor (F), Hertz Global (HTZ), Incyte (INCY), IQVIA (IQV) and This page (NYSE:IMS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMS Health Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.